Literature DB >> 15013220

Comprehensive genomics linking between neural development and cancer: neuroblastoma as a model.

Akira Nakagawara1, Miki Ohira.   

Abstract

Cancer cells are derived from their precursor cells, which normally develop to the matured cells to form individual organs. Neuroblastoma, one of the most common pediatric solid tumors, originates from possible cancer stem cells derived from the neural crest. During the development, neural crest cells segregate into several lineages such as sensory, enteric and sympathetic neurons. However, the genetic events to cause neuroblastoma occur only in the sympathetic precursor cells or cancer stem cells. Furthermore, spontaneous regression of a subset of neuroblastoma found in patients under one year of age mimics a developmentally programmed neuronal cell death that occurs in normal sympathetic neurons during the perinatal period. Thus, the genetic events to cause neuroblastoma may be programmed to occur in a lineage-specific as well as developmentally regulated manner. In this review, we discuss about the molecular link between neural development and the genesis of neuroblastoma based on our comprehensive genomics approach.

Entities:  

Mesh:

Year:  2004        PMID: 15013220     DOI: 10.1016/S0304-3835(03)00457-9

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  25 in total

1.  Calreticulin mediates nerve growth factor-induced neuronal differentiation.

Authors:  Yu-Yin Shih; Akira Nakagawara; Hsinyu Lee; Hsueh-Fen Juan; Yung-Ming Jeng; Dong-Tsamn Lin; Yung-Li Yang; Yeou-Guang Tsay; Min-Chuan Huang; Chien-Yuan Pan; Wen-Ming Hsu; Yung-Feng Liao
Journal:  J Mol Neurosci       Date:  2011-12-07       Impact factor: 3.444

2.  Carnosic acid, a rosemary phenolic compound, induces apoptosis through reactive oxygen species-mediated p38 activation in human neuroblastoma IMR-32 cells.

Authors:  Chia-Wen Tsai; Chia-Yuan Lin; Hui-Hsuan Lin; Jing-Hsien Chen
Journal:  Neurochem Res       Date:  2011-08-11       Impact factor: 3.996

3.  Shutdown of achaete-scute homolog-1 expression by heterogeneous nuclear ribonucleoprotein (hnRNP)-A2/B1 in hypoxia.

Authors:  Mumtaz Kasim; Edgar Benko; Aline Winkelmann; Ralf Mrowka; Jonas J Staudacher; Pontus B Persson; Holger Scholz; Jochen C Meier; Michael Fähling
Journal:  J Biol Chem       Date:  2014-08-14       Impact factor: 5.157

Review 4.  Involvement of midkine in neuroblastoma tumourigenesis.

Authors:  S Kishida; K Kadomatsu
Journal:  Br J Pharmacol       Date:  2014-02       Impact factor: 8.739

5.  Chemotherapy sorting can be used to identify cancer stem cell populations.

Authors:  Liping Li; Bingkun Li; Jialiang Shao; Xiang Wang
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

6.  Neuroblastoma chemotherapy can be augmented by immunotargeting O-acetyl-GD2 tumor-associated ganglioside.

Authors:  S Faraj; M Bahri; S Fougeray; A El Roz; J Fleurence; J Véziers; M D Leclair; E Thébaud; F Paris; S Birklé
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

7.  Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.

Authors:  Hisham F Bahmad; Reda M Chalhoub; Hayat Harati; Georges Daoud; Youssef Fares; Wassim Abou-Kheir; Jolie Bou-Gharios; Sahar Assi; Farah Ballout; Alissar Monzer; Hiba Msheik; Tarek Araji; Mohamad K Elajami; Paola Ghanem; Farah Chamaa; Humam Kadara; Tamara Abou-Antoun
Journal:  Pharmacol Rep       Date:  2020-10-08       Impact factor: 3.024

8.  Calreticulin regulates MYCN expression to control neuronal differentiation and stemness of neuroblastoma.

Authors:  Andy Chi-Lung Lee; Yu-Yin Shih; Fanfan Zhou; Tsi-Chian Chao; Hsinyu Lee; Yung-Feng Liao; Wen-Ming Hsu; Ji-Hong Hong
Journal:  J Mol Med (Berl)       Date:  2019-01-05       Impact factor: 4.599

9.  Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.

Authors:  Fakhera Ikram; Sandra Ackermann; Yvonne Kahlert; Ruth Volland; Frederik Roels; Anne Engesser; Falk Hertwig; Hayriye Kocak; Barbara Hero; Daniel Dreidax; Kai-Oliver Henrich; Frank Berthold; Peter Nürnberg; Frank Westermann; Matthias Fischer
Journal:  Mol Oncol       Date:  2015-11-07       Impact factor: 6.603

Review 10.  Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.

Authors:  M Mimeault; S K Batra
Journal:  Panminerva Med       Date:  2008-03       Impact factor: 5.197

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.